Works matching DE "THERAPEUTIC use of protease inhibitors"
Results: 705
Impact of Nafamostat Mesylate Combined with Continuous Renal Replacement Therapy on Clinical Outcomes, Immune Function, and Oxidative Stress Markers in Patients with Sepsis-Associated Acute Kidney Injury.
- Published in:
- British Journal of Hospital Medicine (17508460), 2025, v. 86, n. 2, p. 1, doi. 10.12968/hmed.2024.0615
- By:
- Publication type:
- Article
The importance of limiting diabetic foot ulcer chronicity.
- Published in:
- Diabetic Foot Journal, 2016, v. 19, n. 3, p. 156
- By:
- Publication type:
- Article
Hepatitis C part 2: Treatment and prevention.
- Published in:
- Practice Nursing, 2012, v. 23, n. 11, p. 540, doi. 10.12968/pnur.2012.23.11.540
- By:
- Publication type:
- Article
Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 4, p. 14, doi. 10.21315/mjms2024.31.4.2
- By:
- Publication type:
- Article
Adding vitamin D3 to the dipeptidyl peptidase-4 inhibitor saxagliptin has the potential to protect β-cell function in LADA patients: A 1-year pilot study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Short-term and long-term effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with renal impairment: a meta-analysis of randomized controlled trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diabetes therapy-focus on Asia: second-line therapy debate: insulin/secretagogues.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Effects of Loading-Dose Statins Combined with PCSK9 Inhibitor Pre-Treatment before Primary Percutaneous Coronary Intervention on the Short-Term Prognosis in Patients with ST-Segment Elevation Myocardial Infarction.
- Published in:
- Cardiovascular Innovations & Applications (CVIA), 2022, v. 7, n. 1, p. 1, doi. 10.15212/CVIA.2022.0011
- By:
- Publication type:
- Article
Preventing Graft-Versus-Host Disease: Transplanters Glimpse Hope Beyond Immunosuppressants.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 13, p. 922, doi. 10.1093/jnci/djt179
- By:
- Publication type:
- Article
Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 19, p. 1470, doi. 10.1093/jnci/djs377
- By:
- Publication type:
- Article
Prescribing pearls: A guide to DPP-4 inhibitors (gliptins).
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 1, p. 223
- By:
- Publication type:
- Article
Newer lipid-lowering therapies in type 2 diabetes.
- Published in:
- Diabetes & Primary Care, 2023, v. 25, n. 5, p. 161
- By:
- Publication type:
- Article
Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Advances in treatments for hepatitis C.
- Published in:
- British Journal of Healthcare Management, 2015, v. 21, n. 9, p. 408, doi. 10.12968/bjhc.2015.21.9.408
- By:
- Publication type:
- Article
Case: Biomarkers in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 2, p. 74
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6696012
- By:
- Publication type:
- Article
Antitumor Effect of Inula viscosa Extracts on DMBA-Induced Skin Carcinoma Are Mediated by Proteasome Inhibition.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6687589
- By:
- Publication type:
- Article
Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 3, p. 1, doi. 10.1111/dme.14780
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 10, p. 919, doi. 10.1007/s40273-013-0080-3
- By:
- Publication type:
- Article
Pharmacokinetic enhancement of protease inhibitor therapy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Secretory leukocyte protease inhibitor reduces inflammation and alveolar bone resorption in LPS-induced periodontitis in rats and in MC3T3-E1 preosteoblasts.
- Published in:
- Animal Cells & Systems, 2016, v. 20, n. 6, p. 344, doi. 10.1080/19768354.2016.1250817
- By:
- Publication type:
- Article
Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2016, v. 25, n. 2, p. 197, doi. 10.15403/jgld.2014.1121.252.th3
- By:
- Publication type:
- Article
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1736, doi. 10.1001/jama.2015.3868
- By:
- Publication type:
- Article
Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1728, doi. 10.1001/jama.2015.3860
- By:
- Publication type:
- Article
Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor-Based Viral Suppression.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 10, p. 1082, doi. 10.1001/jama.2010.1278
- By:
- Publication type:
- Article
In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Stroke Prevention in Patients with Atrial Fibrillation.
- Published in:
- MEDSURG Nursing, 2021, v. 30, n. 6, p. 403, doi. 10.62116/msj.2021.30.6.403
- By:
- Publication type:
- Article
Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Hidden evidence to the West: multicentre, randomised, controlled trials in sepsis and systemic inflammatory response syndrome in Japanese journals.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A novel p.Pro353His SERPINC1 mutation in the thrombin‐binding region affecting stability of Antithrombin molecule in an extended Omani family.
- Published in:
- International Journal of Laboratory Hematology, 2018, v. 40, n. 3, p. e49, doi. 10.1111/ijlh.12808
- By:
- Publication type:
- Article
NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2025, v. 20, p. 1, doi. 10.1186/s13018-025-05517-5
- By:
- Publication type:
- Article
The physiological response of protease inhibition in dystrophic muscle.
- Published in:
- Acta Physiologica, 2013, v. 208, n. 3, p. 234, doi. 10.1111/apha.12114
- By:
- Publication type:
- Article
Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
- Published in:
- Transactions of the Royal Society of Tropical Medicine & Hygiene, 2013, v. 107, n. 10, p. 608, doi. 10.1093/trstmh/trt071
- By:
- Publication type:
- Article
Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders.
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 3, p. 556, doi. 10.1046/j.1365-2141.1999.01748.x
- By:
- Publication type:
- Article
EFFICACY OF PROTEASE INHIBITOR-BASED ANTI-RETROVIRAL THERAPY IN SEVERE HIV-ASSOCIATED THROMBOCYTOPENIA UNRESPONSIVE TO AZT.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 4, p. 1147
- By:
- Publication type:
- Article
HCV protease inhibitors bring new options for patients.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 15, p. 1372, doi. 10.2146/news110051
- By:
- Publication type:
- Article
Two drugs approved for chronic hepatitis C infection.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 13, p. 1176, doi. 10.2146/news110042
- By:
- Publication type:
- Article
FDA's first active medical product surveillance eyes antidiabetic-MI link.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 7, p. 550, doi. 10.2146/news110018
- By:
- Publication type:
- Article
High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pooled analysis of the reports of carfilzomib/ixazomib combinations for relapsed/refractory multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Echocardiographic evaluation of the effects of sacubitril-valsartan on vascular properties in heart failure patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006-2020.
- Published in:
- Diabetes Care, 2022, v. 45, n. 10, p. 2316, doi. 10.2337/dc22-0224
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article